Priority Date: 28.09.12 (IN 2012KOL1120)

CANCER CHEMOTHERAPEUTIC AGENT/FORMULATION, MANUFACTURE AND USE THEREOF

  • Application ID: EP13841638
  • Status: GRANT OF PATENT INTENDED

Applicant

Research organisation logo small
Research Organisation

Attorney

no operation time available
8 offices
active in Legal Services

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 228 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 28.09.2012 - Priority Date (IN 2012KOL1120)
  • 03.04.2014 - Publication A1 (WO2014049619)
  • 05.08.2015 - Publication A1 (EP2900234)